Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Terminated"
topic_facet:"Leukemia"
topic_facet:"Leukemia, Lymphoid"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Terminated%22&filter%5B%5D=topic_facet%3A%22Leukemia%22&filter%5B%5D=topic_facet%3A%22Leukemia%2C+Lymphoid%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Terminated%22&filter%5B%5D=topic_facet%3A%22Leukemia%22&filter%5B%5D=topic_facet%3A%22Leukemia%2C+Lymphoid%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Terminated%22&filter%5B%5D=topic_facet%3A%22Leukemia%22&filter%5B%5D=topic_facet%3A%22Leukemia%2C+Lymphoid%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
PubPharm (234)
1
Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia : A Phase I-II Study of the Combination of Ruxolitinib or Dasatinib With Chemotherapy in Patients With Philadelphia Chromosome (Ph)-Like Acute Lymphoblastic Leukemia (ALL)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Participants With Untreated and Previously Treated Chronic Lymphocytic Leukemia : Phase 3, Randomized Study to Assess the Efficacy and Safety of Ublituximab in Combination With TGR-1202 (Umbralisib) Compared to Obinutuzumab in Combination With Chlorambucil in Patients With Chronic Lymphocytic Leukemia (CLL)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
HCL Single Arm Pilot Study in Treatment of Hyperglycemia of Pediatric ALL : Safety and Feasibility Study of a Hybrid Closed-loop Insulin Delivery System for Children and Young Adults With High Risk Acute Lymphoblastic Leukemia
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Family-Based Behavioral Treatment for Childhood Survivors of Acute Lymphoblastic Leukemia : Family-Based Behavioral Treatment for Childhood Survivors of Acute Lymphoblastic Leukemia
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Study to Assess the Efficacy and Safety of Ublituximab in Combination With Umbralisib and Venetoclax Compared to Ublituximab in Combination With Umbralisib in Subjects With CLL (ULTRA-V) : Phase 2/3 Randomized Study to Assess the Efficacy and Safety of Ublituximab in Combination With Umbralisib and Venetoclax (U2-V) Compared to Ublituximab and Umbralisib (U2) in Subjects With Chronic Lymphocytic Leukemia (CLL)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
huJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia : A Two-Stage Phase 1 Open-Label Study of huJCAR014, CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cells Bearing a Human Binding Domain, in Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and Acute Lymphocytic Leukemia
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors : Allogeneic Hematopoietic Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Blinatumomab Versus Standard of Care Chemotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) : A Phase 3, Randomized, Open Label Study Investigating the Efficacy of the BiTE Antibody Blinatumomab Versus Standard of Care Chemotherapy in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) (TOWER Study)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial : Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) Trial: PRIME
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia : Phase II Trial of Ibrutinib and PD-1 Blockade in High Risk Chronic Lymphocytic Leukemia to Improve Immune Dysfunction
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[24]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Recruitment Status: Terminated
Filter aufheben
Thema: Leukemia
Filter aufheben
Thema: Leukemia, Lymphoid
Medienart
234
Aufsätze
234
E-Artikel
234
E-Ressourcen
Zeitschriftentitel
234
ClinicalTrials.gov
Thema
234
610
Leukemia
Leukemia, Lymphoid
Recruitment Status: Terminated
234
Study Type: Interventional
133
Leukemia, Lymphocytic, Chronic, B-Cell
117
Precursor Cell Lymphoblastic Leukemia-Lymphoma
95
Phase: Phase 2
81
Lymphoma
67
Phase: Phase 1
42
Leukemia, Myeloid
38
Lymphoma, Non-Hodgkin
37
Leukemia, Myeloid, Acute
28
Phase: Phase 1/Phase 2
27
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
25
Myelodysplastic Syndromes
21
Medical Condition: Chronic Lymphocytic Leukemia
18
Lymphoma, B-Cell
18
Lymphoma, Mantle-Cell
18
Preleukemia
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
89
2020-
141
2010-2019
4
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
234
Englisch
Haven't found what you're looking for?
Wird geladen...